The IARC perspective on cervical cancer screening

Autores
Bouvard, Véronique; Wentzensen, Nicolas; Mackie, Anne; Berkhof, Johannes; Brotherton, Julia; Giorgi Rossi, Paolo; Kupets, Rachel; Smith, Robert; Arrossi, Silvina; Bendahhou, Karima; Canfell, Karen; Chirenje, Z. Mike; Chung, Michael H.; del Pino, Marta; de Sanjosé, Silvia; Elfström, Miriam; Franco, Eduardo L.; Hamashima, Chisato; Hamers, Françoise F.; Herrington, C. Simon; Murillo, Raúl; Sangrajrang, Suleeporn; Sankaranarayanan, Rengaswamy; Saraiya, Mona; Schiffman, Mark; Zhao, Fanghui; Arbyn, Marc; Prendiville, Walter; Indave Ruiz, Blanca I.; Mosquera Metcalfe, Isabel; Lauby Secretan, Béatrice
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).
Fil: Bouvard, Véronique. International Agency For Research On Cancer; Francia
Fil: Wentzensen, Nicolas. National Cancer Institute; Estados Unidos
Fil: Mackie, Anne. Public Health England; Reino Unido
Fil: Berkhof, Johannes. University of Amsterdam; Países Bajos
Fil: Brotherton, Julia. VCS Foundation; Australia. University of Melbourne; Australia
Fil: Giorgi Rossi, Paolo. Azienda Unità Sanitaria Locale Di Reggio Emilia; Italia
Fil: Kupets, Rachel. University of Toronto; Canadá
Fil: Smith, Robert. American Cancer Society; Estados Unidos
Fil: Arrossi, Silvina. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Bendahhou, Karima. Casablanca Cancer Registry; Marruecos
Fil: Canfell, Karen. The University Of Sydney; Australia
Fil: Chirenje, Z. Mike. University Of Zimbabwe; Zimbabue
Fil: Chung, Michael H.. University of Emory; Estados Unidos
Fil: del Pino, Marta. Hospital Clinico de Barcelona; España
Fil: de Sanjosé, Silvia. Program for Appropriate Technology in Health; Estados Unidos
Fil: Elfström, Miriam. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia
Fil: Franco, Eduardo L.. McGill University; Canadá
Fil: Hamashima, Chisato. Teikyo University; Japón
Fil: Hamers, Françoise F.. French National Public Health Agency; Francia
Fil: Herrington, C. Simon. University of Edinburgh; Reino Unido
Fil: Murillo, Raúl. Hospital Universitario San Ignacio; Colombia
Fil: Sangrajrang, Suleeporn. National Cancer Institute; Tailandia
Fil: Sankaranarayanan, Rengaswamy. Research Triangle Institute; Estados Unidos
Fil: Saraiya, Mona. Centers for Disease Control and Prevention; Estados Unidos
Fil: Schiffman, Mark. National Cancer Institute; Estados Unidos
Fil: Zhao, Fanghui. Chinese Academy of Medical Sciences & Peking Union Medical College; China
Fil: Arbyn, Marc. Sciensano; Bélgica
Fil: Prendiville, Walter. International Agency For Research On Cancer; Francia
Fil: Indave Ruiz, Blanca I.. International Agency For Research On Cancer; Francia
Fil: Mosquera Metcalfe, Isabel. International Agency For Research On Cancer; Francia
Fil: Lauby Secretan, Béatrice. International Agency For Research On Cancer; Francia
Materia
Screening
Cervical Cancer
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/167258

id CONICETDig_4219a5b827d98d491ec5e801ff846775
oai_identifier_str oai:ri.conicet.gov.ar:11336/167258
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The IARC perspective on cervical cancer screeningBouvard, VéroniqueWentzensen, NicolasMackie, AnneBerkhof, JohannesBrotherton, JuliaGiorgi Rossi, PaoloKupets, RachelSmith, RobertArrossi, SilvinaBendahhou, KarimaCanfell, KarenChirenje, Z. MikeChung, Michael H.del Pino, Martade Sanjosé, SilviaElfström, MiriamFranco, Eduardo L.Hamashima, ChisatoHamers, Françoise F.Herrington, C. SimonMurillo, RaúlSangrajrang, SuleepornSankaranarayanan, RengaswamySaraiya, MonaSchiffman, MarkZhao, FanghuiArbyn, MarcPrendiville, WalterIndave Ruiz, Blanca I.Mosquera Metcalfe, IsabelLauby Secretan, BéatriceScreeningCervical Cancerhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).Fil: Bouvard, Véronique. International Agency For Research On Cancer; FranciaFil: Wentzensen, Nicolas. National Cancer Institute; Estados UnidosFil: Mackie, Anne. Public Health England; Reino UnidoFil: Berkhof, Johannes. University of Amsterdam; Países BajosFil: Brotherton, Julia. VCS Foundation; Australia. University of Melbourne; AustraliaFil: Giorgi Rossi, Paolo. Azienda Unità Sanitaria Locale Di Reggio Emilia; ItaliaFil: Kupets, Rachel. University of Toronto; CanadáFil: Smith, Robert. American Cancer Society; Estados UnidosFil: Arrossi, Silvina. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Bendahhou, Karima. Casablanca Cancer Registry; MarruecosFil: Canfell, Karen. The University Of Sydney; AustraliaFil: Chirenje, Z. Mike. University Of Zimbabwe; ZimbabueFil: Chung, Michael H.. University of Emory; Estados UnidosFil: del Pino, Marta. Hospital Clinico de Barcelona; EspañaFil: de Sanjosé, Silvia. Program for Appropriate Technology in Health; Estados UnidosFil: Elfström, Miriam. Karolinska Huddinge Hospital. Karolinska Institutet; SueciaFil: Franco, Eduardo L.. McGill University; CanadáFil: Hamashima, Chisato. Teikyo University; JapónFil: Hamers, Françoise F.. French National Public Health Agency; FranciaFil: Herrington, C. Simon. University of Edinburgh; Reino UnidoFil: Murillo, Raúl. Hospital Universitario San Ignacio; ColombiaFil: Sangrajrang, Suleeporn. National Cancer Institute; TailandiaFil: Sankaranarayanan, Rengaswamy. Research Triangle Institute; Estados UnidosFil: Saraiya, Mona. Centers for Disease Control and Prevention; Estados UnidosFil: Schiffman, Mark. National Cancer Institute; Estados UnidosFil: Zhao, Fanghui. Chinese Academy of Medical Sciences & Peking Union Medical College; ChinaFil: Arbyn, Marc. Sciensano; BélgicaFil: Prendiville, Walter. International Agency For Research On Cancer; FranciaFil: Indave Ruiz, Blanca I.. International Agency For Research On Cancer; FranciaFil: Mosquera Metcalfe, Isabel. International Agency For Research On Cancer; FranciaFil: Lauby Secretan, Béatrice. International Agency For Research On Cancer; FranciaMassachusetts Medical Society2021-11-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/167258Bouvard, Véronique; Wentzensen, Nicolas; Mackie, Anne; Berkhof, Johannes; Brotherton, Julia; et al.; The IARC perspective on cervical cancer screening; Massachusetts Medical Society; New England Journal of Medicine; 385; 20; 11-11-2021; 1908-19180028-47931533-4406CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nejm.org/doi/10.1056/NEJMsr2030640info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMsr2030640info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:04:59Zoai:ri.conicet.gov.ar:11336/167258instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:04:59.552CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The IARC perspective on cervical cancer screening
title The IARC perspective on cervical cancer screening
spellingShingle The IARC perspective on cervical cancer screening
Bouvard, Véronique
Screening
Cervical Cancer
title_short The IARC perspective on cervical cancer screening
title_full The IARC perspective on cervical cancer screening
title_fullStr The IARC perspective on cervical cancer screening
title_full_unstemmed The IARC perspective on cervical cancer screening
title_sort The IARC perspective on cervical cancer screening
dc.creator.none.fl_str_mv Bouvard, Véronique
Wentzensen, Nicolas
Mackie, Anne
Berkhof, Johannes
Brotherton, Julia
Giorgi Rossi, Paolo
Kupets, Rachel
Smith, Robert
Arrossi, Silvina
Bendahhou, Karima
Canfell, Karen
Chirenje, Z. Mike
Chung, Michael H.
del Pino, Marta
de Sanjosé, Silvia
Elfström, Miriam
Franco, Eduardo L.
Hamashima, Chisato
Hamers, Françoise F.
Herrington, C. Simon
Murillo, Raúl
Sangrajrang, Suleeporn
Sankaranarayanan, Rengaswamy
Saraiya, Mona
Schiffman, Mark
Zhao, Fanghui
Arbyn, Marc
Prendiville, Walter
Indave Ruiz, Blanca I.
Mosquera Metcalfe, Isabel
Lauby Secretan, Béatrice
author Bouvard, Véronique
author_facet Bouvard, Véronique
Wentzensen, Nicolas
Mackie, Anne
Berkhof, Johannes
Brotherton, Julia
Giorgi Rossi, Paolo
Kupets, Rachel
Smith, Robert
Arrossi, Silvina
Bendahhou, Karima
Canfell, Karen
Chirenje, Z. Mike
Chung, Michael H.
del Pino, Marta
de Sanjosé, Silvia
Elfström, Miriam
Franco, Eduardo L.
Hamashima, Chisato
Hamers, Françoise F.
Herrington, C. Simon
Murillo, Raúl
Sangrajrang, Suleeporn
Sankaranarayanan, Rengaswamy
Saraiya, Mona
Schiffman, Mark
Zhao, Fanghui
Arbyn, Marc
Prendiville, Walter
Indave Ruiz, Blanca I.
Mosquera Metcalfe, Isabel
Lauby Secretan, Béatrice
author_role author
author2 Wentzensen, Nicolas
Mackie, Anne
Berkhof, Johannes
Brotherton, Julia
Giorgi Rossi, Paolo
Kupets, Rachel
Smith, Robert
Arrossi, Silvina
Bendahhou, Karima
Canfell, Karen
Chirenje, Z. Mike
Chung, Michael H.
del Pino, Marta
de Sanjosé, Silvia
Elfström, Miriam
Franco, Eduardo L.
Hamashima, Chisato
Hamers, Françoise F.
Herrington, C. Simon
Murillo, Raúl
Sangrajrang, Suleeporn
Sankaranarayanan, Rengaswamy
Saraiya, Mona
Schiffman, Mark
Zhao, Fanghui
Arbyn, Marc
Prendiville, Walter
Indave Ruiz, Blanca I.
Mosquera Metcalfe, Isabel
Lauby Secretan, Béatrice
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Screening
Cervical Cancer
topic Screening
Cervical Cancer
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).
Fil: Bouvard, Véronique. International Agency For Research On Cancer; Francia
Fil: Wentzensen, Nicolas. National Cancer Institute; Estados Unidos
Fil: Mackie, Anne. Public Health England; Reino Unido
Fil: Berkhof, Johannes. University of Amsterdam; Países Bajos
Fil: Brotherton, Julia. VCS Foundation; Australia. University of Melbourne; Australia
Fil: Giorgi Rossi, Paolo. Azienda Unità Sanitaria Locale Di Reggio Emilia; Italia
Fil: Kupets, Rachel. University of Toronto; Canadá
Fil: Smith, Robert. American Cancer Society; Estados Unidos
Fil: Arrossi, Silvina. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Bendahhou, Karima. Casablanca Cancer Registry; Marruecos
Fil: Canfell, Karen. The University Of Sydney; Australia
Fil: Chirenje, Z. Mike. University Of Zimbabwe; Zimbabue
Fil: Chung, Michael H.. University of Emory; Estados Unidos
Fil: del Pino, Marta. Hospital Clinico de Barcelona; España
Fil: de Sanjosé, Silvia. Program for Appropriate Technology in Health; Estados Unidos
Fil: Elfström, Miriam. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia
Fil: Franco, Eduardo L.. McGill University; Canadá
Fil: Hamashima, Chisato. Teikyo University; Japón
Fil: Hamers, Françoise F.. French National Public Health Agency; Francia
Fil: Herrington, C. Simon. University of Edinburgh; Reino Unido
Fil: Murillo, Raúl. Hospital Universitario San Ignacio; Colombia
Fil: Sangrajrang, Suleeporn. National Cancer Institute; Tailandia
Fil: Sankaranarayanan, Rengaswamy. Research Triangle Institute; Estados Unidos
Fil: Saraiya, Mona. Centers for Disease Control and Prevention; Estados Unidos
Fil: Schiffman, Mark. National Cancer Institute; Estados Unidos
Fil: Zhao, Fanghui. Chinese Academy of Medical Sciences & Peking Union Medical College; China
Fil: Arbyn, Marc. Sciensano; Bélgica
Fil: Prendiville, Walter. International Agency For Research On Cancer; Francia
Fil: Indave Ruiz, Blanca I.. International Agency For Research On Cancer; Francia
Fil: Mosquera Metcalfe, Isabel. International Agency For Research On Cancer; Francia
Fil: Lauby Secretan, Béatrice. International Agency For Research On Cancer; Francia
description In May 2018, the World Health Organization (WHO) called for a global initiative to eliminate cervical cancer as a public health problem. To achieve this goal, global scale-up of effective vaccination against the human papillomavirus (HPV) as well as screening for and treatment of cervical cancer are required. Cervical cancer screening was evaluated in 2005 by the International Agency for Research on Cancer (IARC) Handbooks program,1 and a reevaluation was deemed to be timely given the major advances in the field since then. The new handbook provides updated evaluations of the effectiveness of screening methods, which were used as a basis for the update of the WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention.2 We convened an IARC Working Group of 27 scientists from 20 countries to assess the evidence on the current approaches to and technologies used in cervical cancer screening with the use of the newly updated Handbooks Preamble3 (Fig. 1) and Table 1).
publishDate 2021
dc.date.none.fl_str_mv 2021-11-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/167258
Bouvard, Véronique; Wentzensen, Nicolas; Mackie, Anne; Berkhof, Johannes; Brotherton, Julia; et al.; The IARC perspective on cervical cancer screening; Massachusetts Medical Society; New England Journal of Medicine; 385; 20; 11-11-2021; 1908-1918
0028-4793
1533-4406
CONICET Digital
CONICET
url http://hdl.handle.net/11336/167258
identifier_str_mv Bouvard, Véronique; Wentzensen, Nicolas; Mackie, Anne; Berkhof, Johannes; Brotherton, Julia; et al.; The IARC perspective on cervical cancer screening; Massachusetts Medical Society; New England Journal of Medicine; 385; 20; 11-11-2021; 1908-1918
0028-4793
1533-4406
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.nejm.org/doi/10.1056/NEJMsr2030640
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMsr2030640
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Massachusetts Medical Society
publisher.none.fl_str_mv Massachusetts Medical Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269885016571904
score 13.13397